XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Net revenue $ 42,498 $ 35,734 $ 83,869 $ 68,838
Cost of goods sold 7,638 6,672 14,429 13,113
Gross profit 34,860 29,062 69,440 55,725
Operating expenses        
Research and development costs 5,990 3,587 11,763 7,136
Selling, general, and administrative 37,948 26,645 75,190 50,041
Total operating expenses 43,938 30,232 86,953 57,177
Operating loss (9,078) (1,170) (17,513) (1,452)
Other income (expense)        
Other income (expense) 652 1 551 (26)
Interest expense, net (1,104) (537) (1,772) (601)
Total other expense (452) (536) (1,221) (627)
Loss before income taxes (9,530) (1,706) (18,734) (2,079)
Income tax expense 73 178 105 332
Net loss (9,603) (1,884) (18,839) (2,411)
Less: cumulative dividends on Series B convertible preferred stock 0 (473) 0 (942)
Net loss attributable to common stockholders (9,603) (2,357) (18,839) (3,353)
Foreign currency translation adjustment (593) 84 (917) (454)
Comprehensive loss $ (10,196) $ (2,273) $ (19,756) $ (3,807)
Weighted average number of common stocks outstanding:        
Basic 76,481,709 46,919,443 76,465,082 46,885,995
Diluted 76,481,709 46,919,443 76,465,082 46,885,995
Net loss per share attributable to common stockholders:        
Basic $ (0.13) $ (0.05) $ (0.25) $ (0.07)
Diluted $ (0.13) $ (0.05) $ (0.25) $ (0.07)